Posts Tagged: compulsory licensing
Calls for Compulsory Licensing and IP Waivers of COVID-19 Vaccines Ignore Technical Complexities
Though it is not over, it seems that the end of the Covid-19 pandemic may be in sight. A select group of countries has managed to bring …
Why Innovation Would Survive a COVID-19 TRIPS Waiver
Intellectual property protection has played an important role in this pandemic. As some have pointed out, without legal protection for innovative ideas, there may not have been …
Gutting Patents Won’t Speed the COVID-19 Vaccine Rollout
India and South Africa recently urged the World Trade Organization to suspend intellectual property protections for COVID-19 vaccines and treatments. The claim is that this would allow …
India and South Africa’s COVID Vaccine Proposal to the WTO: Why Patent Waiver Must Be Considered Over Compulsory Licensing
While coronavirus spent the majority of 2020 wreaking havoc on earth, pharmaceutical companies have been busy at work trying to invent a vaccine to combat it. Several companies, …
Property Rights and State AGs’ Assault on Remdesivir: A Conservative Perspective
By now, everyone in the IP arena has heard about the demands of more than 30 state and territorial attorneys general (AGs) regarding the promising COVID treatment remdesivir. …
International Approaches to Accelerating Innovation and Access in the Pandemic
In the wake of COVID-19, government officials around the world face unprecedented decisions about when and to what extent they should reopen their respective societies before effective …
Patent Rights and Wrongs in the COVID-19 Pandemic: EU and U.S. Approaches to Compulsory Licensing
As governments around the globe fight the COVID-19 outbreak, pharmaceutical companies race to develop a vaccine and potentially secure a patent for it. To speed the process, …
The Moral Dimension of U.S. Patents
Whenever a national emergency sweeps through, the question of patents is tangentially swiped at in the context of whether any patents will have to be “broken”, or …
Don’t Ignore the Flashing Caution Lights in the Drug Pricing Debate
Trying to rationally address hot button issues in an election year is always a dangerous proposition. That's particularly true as we approach what promises to be one …
The Katy Perry Verdict Proves Our Music Copyright Laws Need a Tune Up
Our music copyright law is out of tune in several ways. The recent multi-million-dollar jury verdict this summer against Katy Perry and Capitol Records illustrates a lack …
Seeds of demise were sown when SCOTUS removed exclusivity from the patent bargain
With the next Supreme Court term beginning in a few weeks we all need to come to terms with the fact that the U.S. has a …
Compulsory Licensing for Medicare Drugs– Another Bad Idea from Capitol Hill
Rep. Lloyd Doggett (D-TX) recently introduced the Medicare Negotiation and Competitive Licensing Act of 2018. Lest the title confuse you, by "competitive licensing" Rep. Doggett means compulsory licensing …
Confused and frustrated, patent policy experts bemoan America’s absurd compulsory licensing patent system
The experts in attendance reminded us of the insanity of the compulsory licensing system that now pervades the U.S. patent marketplace, which when explained in terms …
The Transformation of the American Patent System: Adverse Consequences of Court Decisions
Activist Supreme Court decisions in the last decade have been principally responsible for these changes, stimulated by aggressive technology company incumbent lobbying. The combination of these decisions …
State Department, Universities Blast UN Attack on Patents
If the UN Secretary General and the members of his "High Level Panel on Access to Medicines" thought the State Department was bluffing when it warned against …
